SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(D) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 10, 2011
Neurologix, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware
|
000-13347
|
06-1582875
|
||
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
One Bridge Plaza, Fort Lee, New Jersey 07024
(Address of Principal Executive Offices)
(201) 592-6451
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Neurologix, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on May 10, 2011. At the Annual Meeting, the Company’s stockholders (i) elected Mr. Cornelius E. Golding and Mr. Elliott H. Singer to serve as Class II directors for a term expiring at the Annual Meeting in 2014 and (ii) elected Dr. Martin J. Kaplitt, M.D. to serve as a Class III director for a term expiring at the Annual Meeting in 2012. The votes on these matters are as follows:
1. The election of Mr. Cornelius E. Golding and Mr. Elliott H. Singer to serve as Class II directors for a term expiring at the Annual Meeting in 2014
|
Director
|
For
|
Withhold Authority
|
Broker Non-Votes
|
|
Cornelius E. Golding
|
45,530,313.8027
|
27,031
|
9,172,289
|
|
Elliott H. Singer
|
45,507,813.8027
|
49,531
|
9,172,289
|
2. The election of Dr. Martin J. Kaplitt, M.D. to serve as a Class III director for a term expiring at the Annual Meeting in 2012
|
Director
|
For
|
Withhold Authority
|
Broker Non-Votes
|
|
Dr. Martin J. Kaplitt, M.D.
|
45,486,272.8027
|
71,072
|
9,172,289
|
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Neurologix, Inc.
|
|||
|
By:
|
/s/ Marc L. Panoff
|
||
|
Name:
|
Marc L. Panoff
|
||
|
Title:
|
Chief Financial Officer, Secretary, Treasurer
|
||
Date: May 13, 2011